Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions |
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2024 |
May 31, 2026 |
|
| Commitments and Contingencies Disclosure [Abstract] | |||
| Upfront fee | $ 0.5 | ||
| Development milestone payment | 3.0 | ||
| Clinical material ordered for phase 2 | $ 0.9 | ||
| One-time non-refundable payment | $ 0.5 | ||
| Development and manufacturing costs incurred for phase 3 | 5.1 | ||
| Prepayment of development and manufacturing costs for phase three | $ 4.0 |